Log in to save to my catalogue

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b2b215e9cee4da080fcb6aab138d4fb

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

About this item

Full title

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in medical oncology, 2021, Vol.13, p.1758835920949418-1758835920949418

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Head and neck cancers (HNC) represent the seventh most frequent cancer worldwide, with squamous cell carcinomas as the most frequent histologic subtype. Standard treatment for early stage diseases is represented by single modality surgery or radiotherapy, whereas in the locally advanced and recurrent or metastatic settings a more aggressive multi-m...

Alternative Titles

Full title

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b2b215e9cee4da080fcb6aab138d4fb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b2b215e9cee4da080fcb6aab138d4fb

Other Identifiers

ISSN

1758-8359,1758-8340

E-ISSN

1758-8359

DOI

10.1177/1758835920949418

How to access this item